The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Steven Fishbane

Winthrop University Hospital

Division of Nephrology and Hypertension


NY 11501



Name/email consistency: high



  • Winthrop University Hospital, Division of Nephrology and Hypertension, Mineola, NY 11501, USA. 2010
  • Winthrop Nephrology Associates, 200 Old Country Rd, Suite 135, Mineola, USA. 2010
  • Division of Nephrology, Winthrop-University Hospital, Mineola, New York 11501, USA. 1998 - 2009
  • Winthrop-University Hospital, Mineola, and Brookdale Medical Center, Brooklyn, USA. 2001


  1. A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis. Fishbane, S., Delmez, J., Suki, W.N., Hariachar, S.K., Heaton, J., Chasan-Taber, S., Plone, M.A., Moe, S. Am. J. Kidney Dis. (2010) [Pubmed]
  2. The role of erythropoiesis-stimulating agents in the treatment of anemia. Fishbane, S. Am. J. Manag. Care (2010) [Pubmed]
  3. Posttransplant anemia: the role of sirolimus. Fishbane, S., Cohen, D.J., Coyne, D.W., Djamali, A., Singh, A.K., Wish, J.B. Kidney Int. (2009) [Pubmed]
  4. Erythropoiesis-stimulating agent treatment with full anemia correction: a new perspective. Fishbane, S. Kidney Int. (2009) [Pubmed]
  5. N-acetylcysteine in the prevention of contrast-induced nephropathy. Fishbane, S. Clinical J. American Society Nephrology : Cjasn (2008) [Pubmed]
  6. The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumonia. Fishbane, S., Niederman, M.S., Daly, C., Magin, A., Kawabata, M., de Corla-Souza, A., Choudhery, I., Brody, G., Gaffney, M., Pollack, S., Parker, S. Arch. Intern. Med. (2007) [Pubmed]
  7. What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease. Fishbane, S. Blood Purif. (2007) [Pubmed]
  8. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. Fishbane, S., Durham, J.H., Marzo, K., Rudnick, M. J. Am. Soc. Nephrol. (2004) [Pubmed]
  9. Safety in iron management. Fishbane, S. Am. J. Kidney Dis. (2003) [Pubmed]
  10. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Fishbane, S., Shapiro, W., Dutka, P., Valenzuela, O.F., Faubert, J. Kidney Int. (2001) [Pubmed]
  11. Review of issues relating to iron and infection. Fishbane, S. Am. J. Kidney Dis. (1999) [Pubmed]
  12. Intravenous infusion of total dose iron in peritoneal dialysis patients: a critical appraisal. Fishbane, S. Am. J. Kidney Dis. (1998) [Pubmed]
  13. Iron treatment: impact of safety issues. Fishbane, S. Am. J. Kidney Dis. (1998) [Pubmed]
WikiGenes - Universities